39 unknown. 39 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 39 | Unknown 39 |
Follow Vector Borne Diseases: new trials by email Literature Review of Vector Borne Diseases trials Research Report on Vector Borne Diseases
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Impact RTS,S/AS01 Vaccine in School Aged Children RTS,S/AS01 Malaria Vaccine in School Aged Children Mosquirixs, artemether-lumefantrine - Malaria,Falciparum | Phase 4 | Unknown | Kamuzu University of Health Sciences | 5400 | 2024-06-01 | 2024-05-21 |
| Seasonal Malaria Chemoprevention Rapid Assessment Study Mozambique Sulfadoxine/pyrimethamine plus amodiaquine - Malaria,Falciparum, Chemoprevention | Phase 4 | Unknown | Malaria Consortium | 1000 | 2024-03-26 | 2024-03-29 |
| Primary TBE Vaccination for the Elderly FSME-IMMUN Vaccine - Tick-borne Encephalitis, Vaccine | Phase 4 | Unknown | Region Örebro County | 90 | 2024-01-01 | 2023-11-18 |
| Chemoprevention Efficacy Study Nigeria Standard age based SPAQ administration for SMC - Malaria | Phase 4 | Unknown | Malaria Consortium | 800 | 2023-07-28 | 2023-08-07 |
| Evaluate the Efficacy and Safety of Various Treatment Schemes for Severe Fever With Thrombocytopenia Syndrome(SFTS) Methylprednisolone, intravenous immunoglobulin, Tocilizumab - Severe Fever With Thrombocytopenia Syndrome | Phase 4 | Unknown | Qin Ning | 350 | 2022-08-19 | 2023-07-21 |
| Ivermectin-artemisinin Combination Therapy for Eradication of Malaria Artemether/lumefantrine, Ivermectin - Malaria | Phase 4 | Unknown | Makerere University | 138 | 2022-08-04 | 2022-11-04 |
| Chemoprevention Efficacy Study in Burkina Faso Sulfadoxine pyrimethamine, Amodiaquine - Malaria | Phase 4 | Unknown | Malaria Consortium | 800 | 2022-07-15 | 2023-11-01 |
| Effectiveness and Chemoprevention Efficacy of Implementing Seasonal Malaria Chemoprevention in Karamoja Region, Uganda Sulfadoxine pyrimethamine and amodiaquine, dihydroartemisinin-piperaquine - Malaria | Phase 4 | Unknown | Malaria Consortium | 6805 | 2022-06-01 | 2023-11-01 |
| Escalating Monthly Doses of Tafenoquine in Healthy Volunteers Tafenoquine prophylaxis - Prophylaxis | Phase 4 | Unknown | Naval Medical Research Center | 200 | 2022-05-10 | 2022-04-11 |
| Efficacy and Safety of Artemether-Lumefantrine and Dihydroartemisinin-Piperaquine in Cameroon Artemether-Lumefantrine Drug Combination, Dihydroartemisinin-Piperaquine drug combination - Malaria | Phase 4 | Unknown | University of Yaounde 1 | 184 | 2022-04-11 | 2022-04-22 |
| Effectiveness of Seasonal Malaria Chemoprevention in Nampula Province, Mozambique: Type Two Hybrid Implementation Study Chemopreventive Agent - SPAQ, Control Test - no drugs given - Malaria | Phase 4 | Unknown | Malaria Consortium | 3156 | 2022-01-08 | 2023-11-02 |
| Evaluation of Three Artemisinin-based Combinations for the Treatment of Uncomplicated Malaria in Childreen in Burkina Faso (CHIMIO2) Artemether-lumefantrine - Malaria, Burkina Faso | Phase 4 | Unknown | Centre national de recherche et de formation sur le paludisme | 1050 | 2021-06-01 | 2021-03-03 |
| Efficacy and Safety of Artesunate-amodiaquine and Artemether-lumefantrine for the Treatment of Malaria in Cameroon Artesunate-amodiaquine drug combination, Artemether-lumefantrine drug combination - Falciparum Malaria | Phase 4 | Unknown | University of Yaounde 1 | 184 | 2021-04-05 | 2021-04-02 |
| Seroprevalence of Neutralizing Antibodies Against Japanese Encephalitis Virus Among 6 Years Old Children With 5 Different Immunization Strategies in Zhejiang Province Japanese Encephalitis Vaccine (Vero Cell), Inactivated;, No prospective interventions - Japanese Encephalitis, Vaccine Preventable Disease | Phase 4 | Unknown | Zhejiang Provincial Center for Disease Control and Prevention | 712 | 2021-03-01 | 2022-11-15 |
| Optimizing Malaria Treatment for HIV-Malaria Co-infected Individuals Artemether-lumefantrine - HIV Coinfection, Malaria | Phase 4 | Unknown | Makerere University | 888 | 2021-01-18 | 2023-01-06 |
| Drug Combinations of Atovaquone-Proguanil (AP) With ACT Artesunate and Pyronaridine, Atovaquone Proguanil and Artesunate Pyronaridine, Atovaquone Proguanil and Artesunate Mefloquine - Plasmodium Falciparum Malaria (Drug Resistant) | Phase 4 | Unknown | Armed Forces Research Institute of Medical Sciences, Thailand | 252 | 2018-10-04 | 2021-03-02 |
| Azithromycin to Prevent Post-discharge Morbidity and Mortality in Kenyan Children Azithromycin, Placebo - Pneumonia, Diarrhea | Phase 4 | Unknown | University of Washington | 1400 | 2016-06-28 | 2023-12-04 |
| Malaria Elimination Pilot Study in Military Forces in Cambodia DHA-PIP, Primaquine, Artesunate + Mefloquine - Malaria, Parasitic Diseases | Phase 4 | Unknown | Armed Forces Research Institute of Medical Sciences, Thailand | 1050 | 2016-01-01 | 2021-03-02 |
| Application of a TBE-Vaccine in Obese Persons FSME-IMMUN Vaccine - Tick Borne Encephalitis | Phase 4 | Unknown | Medical University of Vienna | 73 | 2015-04-15 | 2019-09-10 |
| Ketotifen as a Treatment for Vascular Leakage During Dengue Fever Ketotifen, Placebo - Dengue Fever, Pleural Effusion | Phase 4 | Unknown | National University Hospital, Singapore | 110 | 2015-03-01 | 2016-02-04 |
Showing 20 of 39. Sign in to see all of them.
Malaria (25) · Malaria, Falciparum (8) · Anemia (2) · Encephalitis, Japanese (2) · Encephalitis, Tick-Borne (2) · Malaria, Vivax (2) · Chagas Disease (1) · Coinfection (1) · Death (1) · Dementia (1) · Dengue (1) · Diarrhea (1) · HIV Infections (1) · Heart Failure (1) · Helminthiasis (1)
Infections (39) · Mosquito-Borne Diseases (34) · Protozoan Infections (33) · Parasitic Diseases (32) · RNA Virus Infections (7) · Virus Diseases (7) · Malaria (6) · Arbovirus Infections (5) · Brain Diseases (5) · Central Nervous System Diseases (5) · Flaviviridae Infections (5) · Flavivirus Infections (5) · Nervous System Diseases (5) · Central Nervous System Infections (4)
Artemether, Lumefantrine Drug Combination (10) · Amodiaquine (5) · fanasil, pyrimethamine drug combination (5) · Artesunate (3) · Pyrimethamine (3) · FSME-IMMUN vaccine (2) · Primaquine (2) · atovaquone, proguanil drug combination (2) · bendiocarb (2) · pyronaridine tetraphosphate, artesunate drug combination (2) · Acetaminophen (1) · Albendazole (1) · Aspirin (1) · Azithromycin (1) · Chloroquine (1)
Malaria Consortium (5) · Armed Forces Research Institute of Medical Sciences, Thailand (3) · London School of Hygiene and Tropical Medicine (3) · Makerere University (3) · Charite University, Berlin, Germany (2) · University of Khartoum (2) · University of Yaounde 1 (2) · Banaras Hindu University (1) · Bandim Health Project (1) · Centre national de recherche et de formation sur le paludisme (1) · Federal University of Bahia (1) · KEMRI-Wellcome Trust Collaborative Research Program (1) · Kamuzu University of Health Sciences (1) · Khon Kaen University (1) · Liverpool School of Tropical Medicine (1)
Uganda (4) · Cambodia (3) · Sudan (3) · Burkina Faso (2) · China (2) · Ghana (2) · Kenya (2) · Nigeria (2) · Vietnam (2) · Austria (1) · Brazil (1) · Guinea-Bissau (1) · India (1) · Malawi (1) · Mozambique (1)
Mariusz Wojnarski, MD (3) · Wilfred Fon Mbacham, PhD (2) · Abraham V Hodgson, MD, MPH, PhD (1) · Adama Gansane, PhD (1) · Anna Rosanas-Urgell, MD, PhD (1) · Annette Olsen, PhD (1) · Ashley L St John (1) · Badara Cisse, PhD (1) · Baltazar Candrinho, MD (1) · Bashir A Ismail, MSc (1) · Celestino Obua, PhD (1) · Chanthap Lon, MD (1) · Cheikh Sokhna, PhD (1) · Craig Bonnington (1) · Daniel Chandramohan, PHD (1)
PMID 21631932, PMID 22232457, PMID 22882836, PMID 24736370, PMID 25421474, PMID 25811379, PMID 27764102, PMID 27875528, PMID 29229808, PMID 30326952, PMID 32528467, PMID 32552759, PMID 34031050, PMID 34559992, PMID 35152295, PMID 36149743, PMID 37269941, PMID 38196920, PMID 39826559, PMID 40257829, PMID 41285436, PMID 41382293, PMID 41542944
R01HD079695 (1), R01NS064905 (1)